COMMUNIQUÉS West-GlobeNewswire

Six-month interim report (Q2) 2024

22/08/2024 - 17:49

Company release No. 16/2024 ALK delivers 21% organic revenue growth with an operating profit margin of 19% in Q2 (unaudited) Revenue growth was driven by a continued strong momentum in tablet sales, and improved [...]

ALK upgrades its full-year revenue and earnings outlook

22/08/2024 - 17:38

ALK ( ALKB:DC / OMX: ALK B / AKBLF ) today announced that the full-year financial outlook has been upgraded to reflect the current performance and outlook for the remainder of the year. Revenue is now expected to grow [...]

ProLynx annonce des résultats précliniques pour le sémaglutide à action prolongée nécessitant une administration mensuelle

22/08/2024 - 17:27

SAN FRANCISCO, 22 août 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. a annoncé aujourd'hui que sa technologie avait permis de créer un sémaglutide à action prolongée pouvant être administré une fois par mois. La technologie de [...]

KFSHRC Sets New Global Standards with VR Technology at AMEE 2024

22/08/2024 - 17:17

RIYADH, Saudi Arabia, Aug. 22, 2024 (GLOBE NEWSWIRE) -- By continuously adopting new technologies, KFSHRC ensures that its trainees are well-prepared for today’s medical challenges and equipped with the skills and [...]

Harvard Dental and UCLA Medical Graduate Dr. Jacob Taylor Joins Center for Oral & Facial Surgery

22/08/2024 - 17:00

SAN DIEGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Oral and maxillofacial surgeon Jacob T. Taylor , DMD, MD, has joined the Center for Oral & Facial Surgery , the oldest and largest oral and maxillofacial surgery (OMS) [...]

PharmAla Launches MDMA Clinical Trial Tool for Researchers

22/08/2024 - 15:07

TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

22/08/2024 - 15:00

TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) technology company developing innovative neuroscientific [...]

Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan

22/08/2024 - 15:00

TAMPA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. ("Inhibitor") (OTCQB: INTI) today provided an update on development efforts for its itraconazole formulation for the treatment of Basal Cell [...]

Aviv Clinics Congratulates Peter Paltchik on Winning Bronze at the 2024 Paris Olympics

22/08/2024 - 15:00

Paltchik’s training included a unique protocol centered around hyperbaric oxygen therapy, which is available at Aviv Clinics for athletes of all levels ORLANDO, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Aviv Clinics , one [...]

Thomas L. Tran, Former Chief Financial Officer of Molina Healthcare, Joins Clover Health’s Board of Directors

22/08/2024 - 15:00

FRANKLIN, Tenn., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]

Tevogen Bio Secures $6 Million Series C Preferred Stock Investment

22/08/2024 - 15:00

WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically [...]

Asensus Surgical Announces Closing of Acquisition by KARL STORZ

22/08/2024 - 14:58

KARL STORZ acquires US-headquartered company to create a surgical robotics hub and drive Perfomance-Guided Surgery™ RESEARCH TRIANGLE PARK, N.C. and TUTTLINGEN, Germany, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Asensus [...]

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress

22/08/2024 - 14:30

DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded subgroup data from the landmark REDUCE-IT ® cardiovascular [...]

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

22/08/2024 - 14:30

The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform The objective of Phase 2 is to develop and demonstrate new telesurgery capabilities by [...]

TOMI Environmental Solutions Expands Partnership With A Global Leader in Laboratory Services

22/08/2024 - 14:30

$715,000 Order Includes SteraMist Mobile Equipment and A Custom Engineered System FREDERICK, Md., Aug. 22, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company [...]

Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound Gel

22/08/2024 - 14:30

Company’s First Distribution Agreement in Middle East WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has [...]

SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Board

22/08/2024 - 14:12

Professor Peled is the Director of the Oncology Department at the Shaare Zedek Medical Center , Jerusalem , Israel, and the head of the Global Multidisciplinary Practice Standards Committee (GMPSC) of the IASLC TEL AVIV [...]

Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions

22/08/2024 - 14:00

Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company [...]

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

22/08/2024 - 14:00

WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives [...]